Jie Shen

1.2k total citations
65 papers, 902 citations indexed

About

Jie Shen is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jie Shen has authored 65 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 21 papers in Surgery and 19 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jie Shen's work include Cancer Immunotherapy and Biomarkers (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Jie Shen is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (6 papers). Jie Shen collaborates with scholars based in China, United States and Germany. Jie Shen's co-authors include Qin Liu, Baorui Liu, Weijie Zhang, Huifang Su, Yan Lü, Wenlong Zhang, Pingping Shen, Ling Liu, Wei Zheng and Yuncheng Bei and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Biomaterials.

In The Last Decade

Jie Shen

62 papers receiving 885 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jie Shen China 15 443 252 239 203 187 65 902
Laurentiu M. Pop United States 19 318 0.7× 297 1.2× 376 1.6× 170 0.8× 90 0.5× 41 931
Takeo Fujii United States 17 509 1.1× 301 1.2× 182 0.8× 266 1.3× 99 0.5× 76 1.3k
Xueliang Zhou China 16 258 0.6× 372 1.5× 99 0.4× 259 1.3× 179 1.0× 82 901
Rosa Tambaro Italy 18 468 1.1× 258 1.0× 127 0.5× 172 0.8× 305 1.6× 52 1.0k
E.H. Tan Singapore 16 605 1.4× 211 0.8× 156 0.7× 399 2.0× 203 1.1× 46 1.1k
Wenju Chang China 20 535 1.2× 403 1.6× 210 0.9× 292 1.4× 313 1.7× 79 1.3k
Lucy Boyce Kennedy United States 8 715 1.6× 343 1.4× 478 2.0× 235 1.2× 99 0.5× 20 1.3k
Marilena Di Napoli Italy 16 433 1.0× 331 1.3× 140 0.6× 169 0.8× 119 0.6× 64 1.0k
Tomoya Tsukada Japan 21 401 0.9× 337 1.3× 196 0.8× 409 2.0× 326 1.7× 66 1.1k
Niamh M. Keegan United States 9 770 1.7× 164 0.7× 334 1.4× 280 1.4× 103 0.6× 28 1.1k

Countries citing papers authored by Jie Shen

Since Specialization
Citations

This map shows the geographic impact of Jie Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Shen more than expected).

Fields of papers citing papers by Jie Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Shen. The network helps show where Jie Shen may publish in the future.

Co-authorship network of co-authors of Jie Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Jie Shen. A scholar is included among the top collaborators of Jie Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Shen. Jie Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xiaopeng, Enjun Xie, Shumin Sun, et al.. (2025). Flavonoids for gastrointestinal tract local and associated systemic effects: A review of clinical trials and future perspectives. Journal of Advanced Research. 77. 15–41. 13 indexed citations
2.
Huang, Shu-Ting, Yan Zhao, & Jie Shen. (2025). Advances in integrating biomaterials with CAR-T cells for enhancing solid tumor therapy. Chinese Journal of Cancer Research. 37(5). 742–758. 1 indexed citations
3.
4.
5.
Chang, Xiaofeng, Wu Sun, Qin Liu, et al.. (2024). Design of a single-center, phase II trial to explore the efficacy and safety of ‘R-ISV-RO’ treatment in advanced tumors. Future Oncology. 20(17). 1139–1149. 2 indexed citations
6.
Liu, Chenxi, Hailong Zhang, Qin Liu, et al.. (2024). An Advanced Intrahepatic Cholangiocarcinoma Patient Benefits from Personalized Immunotherapy. Inflammation. 47(5). 1699–1705. 2 indexed citations
7.
Shen, Jie, Cheng Chen, Zhen Chen, et al.. (2023). CCL5 promotes the proliferation and metastasis of bladder cancer via the JAK2/STAT3 signaling pathway. Translational Andrology and Urology. 12(12). 1845–1858. 7 indexed citations
8.
Zhuang, Qianfeng, Min Fan, Jie Shen, et al.. (2021). Overexpression of Capns1 Predicts Poor Prognosis and Correlates with Tumor Progression in Renal Cell Carcinoma. Urologia Internationalis. 105(7-8). 697–704. 1 indexed citations
9.
Bian, Lijuan, et al.. (2021). A Case Report of Non-Bacterial Cystitis Caused by Immune Checkpoint Inhibitors. Frontiers in Immunology. 12. 788629–788629. 11 indexed citations
10.
Cao, Lei, Miao Hou, Ling Sun, et al.. (2021). Decreased Flow-Mediated Dilatation in Children With Type 1 Diabetes: A Systematic Review and Meta-Analysis. Angiology. 72(10). 908–915. 6 indexed citations
11.
Shen, Jie, Ling Yuan, Yang Yan, et al.. (2020). A novel device to capture circulating tumor cells: Quantification and molecular analysis in lung cancer patients. Journal of Biomaterials Applications. 35(1). 49–58. 2 indexed citations
12.
Wang, Jiaqi, et al.. (2020). Survey and intervention study of sleep in children with postural tachycardia syndrome. Chinese Journal of Child Health Care. 28(4). 374. 1 indexed citations
13.
Zhang, Wenlong, Ling Liu, Huifang Su, et al.. (2019). Chimeric antigen receptor macrophage therapy for breast tumours mediated by targeting the tumour extracellular matrix. British Journal of Cancer. 121(10). 837–845. 223 indexed citations
14.
Liang, Fei, Zhenyu Wu, Miao Mo, et al.. (2019). Comparison of treatment effect from randomised controlled phase II trials and subsequent phase III trials using identical regimens in the same treatment setting. European Journal of Cancer. 121. 19–28. 20 indexed citations
15.
Yan, Jing, Ju Dong Yang, Wei Ren, et al.. (2018). Induction Chemotherapy with Paclitaxel Liposome, Nedaplatin, and Fluorouracil in Patients with Locally Advanced Nasopharyngeal Carcinoma: A Phase II Study. International Journal of Radiation Oncology*Biology*Physics. 102(3). e374–e375. 2 indexed citations
16.
Shen, Jie, Qianfeng Zhuang, Zhen Chen, et al.. (2017). Capn4 induces human renal cancer cell proliferation by activating NF-κB signaling pathway through FAK phosphorylation.. PubMed Central. 10(7). 7466–7474. 2 indexed citations
17.
Shen, Jie, Zhen Chen, Qianfeng Zhuang, et al.. (2016). Prognostic Value of Serum Lactate Dehydrogenase in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. PLoS ONE. 11(11). e0166482–e0166482. 38 indexed citations
18.
Tang, Yunjia, Xiang Gao, Jie Shen, Ling Sun, & Wenhua Yan. (2016). Epidemiological and Clinical Characteristics of Kawasaki Disease and Factors Associated with Coronary Artery Abnormalities in East China: Nine Years Experience. Journal of Tropical Pediatrics. 62(2). 86–93. 25 indexed citations
19.
Huang, Min, et al.. (2015). IVIG inhibits TNF-α-induced MMP9 expression and activity in monocytes by suppressing NF-κB and P38 MAPK activation.. PubMed. 8(12). 15879–86. 14 indexed citations
20.
Zhu, Beibei, et al.. (2014). The relationship between patients’ age and prognosis outcome after cardiopulmonary resuscitation in adults: A meta-analysis. European Geriatric Medicine. 5(5). 323–329. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laurentiu M. Pop Breakdown of academic impact, for papers by Takeo Fujii Breakdown of academic impact, for papers by Xueliang Zhou Breakdown of academic impact, for papers by Rosa Tambaro Breakdown of academic impact, for papers by E.H. Tan Breakdown of academic impact, for papers by Wenju Chang Breakdown of academic impact, for papers by Lucy Boyce Kennedy Breakdown of academic impact, for papers by Marilena Di Napoli Breakdown of academic impact, for papers by Tomoya Tsukada Breakdown of academic impact, for papers by Niamh M. Keegan
Rankless by CCL
2026